Ann: Emyria Secures $2.525M in Strongly Supported Placement, page-5

Although it might seem ok, Actually Shameful The Directors Have Driven The Share Price Down To This Price-Point & Now Buy…..Without Shareholders Having The Same Opportunity, and also suffering further dilution & wealth destruction along the way, Directors may have other information at hand we don’t?.

Sorry but I also still have concerns over the auditors report ( The Groups ability to continue as a going concern ) & Is this one of the reasons for the Cap Raise?.

Still ever hopeful Rx7,9 to the Rescue?

Cheers.

Regards